David Katz Compugen LTD Transaction History

Matrix Asset Advisors Inc

$835 Million
Q1 2024

A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Compugen LTD stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 90,833 shares of CGEN stock, worth $178,032. This represents 0.03% of its overall portfolio holdings.

Number of Shares

90,833

Previous 109,656 17.17%

Holding current value

$178,032

Previous $217,000 7.83%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$1.75 - $2.95 $32,940 - $55,527	-18,823 Reduced 17.17%	90,833 $234,000
Q4 2022 Jan 19, 2023	SELL	$0.65 - $1.2 $2,823 - $5,212	-4,344 Reduced 3.81%	109,656 $0
Q3 2022 Oct 24, 2022	BUY	$0.77 - $2.32 $13,860 - $41,760	18,000 Added 18.75%	114,000 $75,000
Q2 2022 Jul 15, 2022	SELL	$1.57 - $3.33 $3,510 - $7,445	-2,236 Reduced 2.28%	96,000 $178,000
Q4 2021 Feb 10, 2022	SELL	$4.09 - $7.16 $28,630 - $50,120	-7,000 Reduced 6.65%	98,236 $422,000

Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $12,118 - $16,158	-1,764 Reduced 1.65%	105,236 $871,000
Q1 2021 May 13, 2021	BUY	$7.67 - $13.77 $11,505 - $20,655	1,500 Added 1.42%	107,000 $919,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $72,420 - $107,700	6,000 Added 6.03%	105,500 $1.28 Million
Q3 2020 Nov 12, 2020	BUY	$14.16 - $19.45 $56,640 - $77,800	4,000 Added 4.19%	99,500 $1.62 Million
Q2 2020 Aug 13, 2020	SELL	$6.97 - $17.12 $1,394 - $3,424	-200 Reduced 0.21%	95,500 $1.43 Million
Q1 2020 May 11, 2020	BUY	$5.79 - $11.83 $6,948 - $14,196	1,200 Added 1.27%	95,700 $695,000
Q2 2019 Aug 14, 2019	SELL	$2.8 - $4.14 $14,000 - $20,700	-5,000 Reduced 5.03%	94,500 $363,000
Q1 2019 May 10, 2019	SELL	$2.35 - $4.19 $11,750 - $20,950	-5,000 Reduced 4.78%	99,500 $412,000
Q4 2018 Feb 12, 2019	BUY	$2.17 - $3.8 $39,060 - $68,400	18,000 Added 20.81%	104,500 $227,000
Q1 2018 May 15, 2018	BUY	$2.5 - $4.45 $5,000 - $8,900	2,000 Added 2.37%	86,500 $385,000
Q4 2017 Feb 13, 2018	SELL	$2.35 - $4.0 $4,700 - $8,000	-2,000 Reduced 2.31%	84,500 $211,000
Q3 2017 Nov 14, 2017	BUY	$2.75 - $3.95 $2,750 - $3,950	1,000 Added 1.17%	86,500 $329,000
Q3 2015 Nov 10, 2015	BUY	N/A	500 Added 0.59%	85,500 $442,000
Q4 2014 Feb 10, 2015	BUY	N/A	3,000 Added 3.66%	85,000 $708,000
Q2 2014 Aug 11, 2014	BUY	N/A	2,000 Added 2.5%	82,000 $737,000
Q1 2014 May 08, 2014	SELL	N/A	-5,000 Reduced 5.88%	80,000 $841,000
Q4 2013 Feb 07, 2014	BUY	N/A	85,000	85,000 $761,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.7M

Call Options Held

131K

Put Options Held

76K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $170M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track David Katz's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.

Account